NASDAQ : PROF

Profound Medical Corp. — Financial statements

Healthcare · Medical Devices · Canada

Last price 6.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 240.36M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Profound Medical Corp. (PROF) reported revenue of 19.09M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue8.63M6.37M2.44M393.00K2.00M3.15M
Other Revenue10.45M9.73M8.24M6.81M4.68M3.72M
Revenue19.09M16.10M10.68M7.20M6.68M6.87M
Cost of Revenue5.38M4.71M3.64M2.89M3.66M3.92M
Gross Profit13.70M11.39M7.04M4.31M3.02M2.95M
Selling, General & Admin28.46M32.05M23.13M18.54M17.93M17.97M
Research & Development20.61M20.60M16.96M14.42M14.69M15.28M
Operating Expenses49.07M52.65M40.10M32.96M32.62M33.24M
Operating Income-35.37M-41.25M-33.06M-28.65M-29.60M-30.29M
Interest Expense-174.00K-67.00K
Interest & Investment Income995.00K1.07M1.44M775.00K803.00K205.00K
Currency Exchange Gain (Loss)1.86M-2.13M3.81M-575.00K3.10M-286.00K
Other Non Operating Income (Expenses)15.00K-155.00K
EBT Excluding Unusual Items-32.52M-42.32M-27.82M-28.45M-25.86M-30.59M
Impairment of Goodwill-2.52M
Pretax Income-32.52M-42.32M-27.82M-28.45M-28.38M-30.59M
Income Tax Expense227.00K252.00K-2.00K-128.00K287.00K105.00K
Net Income-32.74M-42.57M-27.82M-28.32M-28.67M-30.70M
Net Income to Common-32.74M-42.57M-27.82M-28.32M-28.67M-30.70M
Shares Outstanding (Basic)33.37M30.23M24.77M21.18M20.83M20.46M
Shares Outstanding (Diluted)33.37M30.23M24.77M21.18M20.83M20.46M
EPS (Basic)-0.98-1.41-1.12-1.34-1.38-1.50
EPS (Diluted)-0.98-1.41-1.12-1.34-1.38-1.50
Free Cash Flow-36.28M-38.38M-23.45M-22.61M-25.80M-22.39M
Free Cash Flow Per Share-1.09-1.27-0.95-1.07-1.24-1.09
Gross Margin71.79%70.77%65.89%59.90%45.22%42.95%
Operating Margin-185.31%-256.27%-309.57%-397.99%-443.08%-440.73%
Profit Margin-171.56%-264.44%-260.45%-393.43%-429.11%-446.66%
Free Cash Flow Margin-190.07%-238.43%-219.60%-314.06%-386.17%-325.80%
EBITDA-34.88M-40.69M-32.13M-27.72M-28.83M-29.61M
EBITDA Margin-182.74%-252.79%
D&A For EBITDA491.00K560.00K936.00K929.00K776.00K681.00K
EBIT-35.37M-41.25M-33.06M-28.65M-29.60M-30.29M
EBIT Margin-185.31%-256.27%
Revenue as Reported19.09M16.10M10.68M7.20M6.68M6.87M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents38.27M59.72M54.91M26.21M46.52M67.15M
Cash & Short-Term Investments38.27M59.72M54.91M26.21M46.52M67.15M
Accounts Receivable9.01M7.20M6.43M6.75M5.84M1.41M
Other Receivables607.00K618.00K534.00K507.00K
Receivables9.61M7.20M7.04M7.29M6.34M1.41M
Inventory10.46M8.24M5.80M6.99M7.94M7.41M
Prepaid Expenses523.00K928.00K1.31M1.41M1.22M1.15M
Total Current Assets58.86M76.09M69.06M41.90M62.02M77.12M
Property, Plant & Equipment3.32M882.00K821.00K1.57M1.72M1.90M
Goodwill2.69M
Other Intangible Assets121.00K138.00K261.00K490.00K680.00K1.44M
Long-Term Accounts Receivable300.00K3.62M
Long-Term Deferred Tax Assets81.00K66.00K87.00K
Total Assets62.38M77.47M70.23M43.96M64.42M86.78M
Accounts Payable955.00K1.56M1.32M865.00K2.03M3.18M
Accrued Expenses3.13M3.81M2.83M2.42M
Current Portion of Long-Term Debt4.51M1.74M2.10M523.00K
Current Portion of Leases119.00K213.00K257.00K259.00K239.00K250.00K
Current Income Taxes Payable63.00K39.00K298.00K
Current Unearned Revenue342.00K445.00K419.00K721.00K471.00K477.00K
Other Current Liabilities621.00K248.00K
Total Current Liabilities9.11M6.08M6.57M6.37M4.18M4.16M
Long-Term Debt4.50M2.92M5.00M6.65M
Long-Term Leases2.75M203.00K504.00K817.00K1.13M
Long-Term Unearned Revenue618.00K388.00K49.00K728.00K764.00K875.00K
Long-Term Deferred Tax Liabilities59.00K
Other Long-Term Liabilities92.00K79.00K71.00K73.00K
Total Liabilities12.58M11.04M9.81M12.73M12.42M6.16M
Common Stock325.38M323.84M281.55M222.21M205.82M219.58M
Additional Paid-In Capital25.69M25.31M21.30M20.81M18.70M16.99M
Retained Earnings-304.33M-287.74M-245.17M-217.35M-189.36M-160.69M
Comprehensive Income & Other3.07M5.03M2.74M5.57M16.84M4.75M
Shareholders' Equity49.81M66.43M60.42M31.22M52.00M80.62M
Total Liabilities & Equity62.38M77.47M70.23M43.96M64.42M86.78M
Total Debt7.38M4.71M5.12M7.87M8.23M1.38M
Net Cash (Debt)30.89M55.01M49.79M18.35M38.29M65.78M
Net Cash Per Share0.931.822.010.871.843.21
Filing Date Shares Outstanding36.53M36.29M30.04M24.43M20.91M20.78M
Total Common Shares Outstanding36.53M36.29M30.04M21.37M20.88M20.78M
Working Capital49.75M70.01M62.50M35.53M57.84M72.97M
Book Value Per Share1.361.832.011.462.493.88
Tangible Book Value49.69M66.30M60.16M30.73M51.32M76.49M
Tangible Book Value Per Share1.361.832.001.442.463.68
Machinery176.00K176.00K542.00K1.20M
Leasehold Improvements542.00K542.00K542.00K542.00K1.83M578.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-32.74M-42.57M-27.82M-28.32M-28.67M-30.70M
Depreciation & Amortization491.00K560.00K936.00K929.00K1.00M1.01M
Other Amortization600.00K866.00K
Asset Writedown & Restructuring Costs2.52M
Stock-Based Compensation4.97M5.49M2.58M3.42M4.24M7.21M
Provision & Write-off of Bad Debts-307.00K146.00K
Other Operating Activities102.00K26.00K562.00K682.00K132.00K132.00K
Change in Accounts Receivable-5.09M-172.00K186.00K-956.00K-1.42M2.00M
Change in Inventory-2.79M-2.82M656.00K353.00K-1.86M-2.49M
Change in Accounts Payable-1.16M378.00K815.00K1.35M-566.00K-356.00K
Change in Unearned Revenue218.00K371.00K-948.00K187.00K
Change in Income Taxes69.00K42.00K-299.00K311.00K-13.00K
Change in Other Net Operating Assets-194.00K464.00K31.00K-158.00K-2.09M-13.00K
Operating Cash Flow-36.10M-38.21M-23.45M-22.61M-25.80M-22.36M
Capital Expenditures-176.00K-176.00K-32.00K
Sale (Purchase) of Intangibles-66.00K-66.00K-561.00K
Investing Cash Flow-242.00K-242.00K-593.00K
Long-Term Debt Issued7.27M
Total Debt Issued7.27M
Long-Term Debt Repaid-290.00K-2.56M-912.00K-356.00K-386.00K
Lease Payments-312.00K-386.00K
Total Debt Repaid-290.00K-2.56M-912.00K-356.00K-386.00K
Net Debt Issued (Repaid)-290.00K-2.56M-912.00K6.92M-386.00K
Issuance of Common Stock42.44M42.44M62.15M2.67M263.00K6.43M
Other Financing Activities-1.02M-1.02M-4.89M-149.00K-99.00K
Financing Cash Flow41.43M41.14M54.70M1.76M7.03M5.95M
Foreign Exchange Rate Adjustments-2.01M2.12M-2.54M549.00K-1.87M244.00K
Net Cash Flow3.08M4.81M28.70M-20.30M-20.64M-16.76M
Free Cash Flow-36.28M-38.38M-23.45M-22.61M-25.80M-22.39M
Free Cash Flow Margin-190.07%-238.43%-219.60%-314.06%-386.17%-325.80%
Free Cash Flow Per Share-1.09-1.27-0.95-1.07-1.24-1.09
Levered Free Cash Flow-24.82M-20.90M-15.05M-13.15M-18.78M-7.22M
Unlevered Free Cash Flow-24.82M-20.90M-15.05M-13.15M-18.68M-7.18M
Free Cash Flow After Leases-36.28M-38.38M-23.45M-22.61M-26.11M-22.78M
Cash Interest Paid11.00K
Change in Working Capital-8.92M-1.71M591.00K540.00K-5.63M-877.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization240.36M285.08M225.40M202.00M223.35M234.04M
Enterprise Value208.92M264.69M205.78M175.88M177.59M163.33M
Last Close Price6.577.877.518.4910.8911.23
PS Ratio12.5917.7121.1028.0633.4334.05
PB Ratio4.834.293.736.474.292.90
P/TBV Ratio4.844.303.756.574.353.06
EV/Sales Ratio10.9516.4419.2724.4326.5823.77
Debt / Equity Ratio0.150.070.090.250.160.02
Net Debt / Equity Ratio-0.62-0.83-0.82-0.59-0.74-0.82
Net Debt / EBITDA Ratio0.891.351.550.661.332.22
Net Debt / FCF Ratio0.851.432.120.811.482.94
Asset Turnover0.340.220.190.130.090.07
Inventory Turnover0.570.670.570.390.480.61
Quick Ratio5.2511.029.445.2612.6316.50
Current Ratio6.4612.5310.526.5814.8218.56
Return on Equity (ROE)-73.53%-67.12%-60.70%-68.06%-43.23%-34.50%
Return on Assets (ROA)-39.46%-34.91%-36.19%-33.05%-24.47%-19.79%
Return on Capital Employed (ROCE)-66.40%-57.80%-51.90%-76.20%-49.10%-36.70%
Earnings Yield-15.17%-14.93%-12.34%-14.02%-12.84%-13.12%
FCF Yield-15.09%-13.46%-10.41%-11.19%-11.55%-9.57%
Buyback Yield / Dilution-20.87%-22.08%-16.91%-1.69%-1.79%-18.33%